Research and Markets: Personalized Medicine in Oncology Partnering Terms and Agreements Report 2014

Research and Markets (http://www.researchandmarkets.com/research/mw7c2k/personalized) has announced the addition of the "Personalized Medicine in Oncology Partnering Terms and Agreements" report to their offering.

The Personalized Medicine in Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements entered into by the world's leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter personalized medicine in oncology partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in personalized medicine in oncology dealmaking

Chapter 3 - Leading personalized medicine in oncology deals

Chapter 4 - Big pharma personalized medicine in oncology deals

Chapter 5 - Personalized medicine in oncology dealmaking directory

Chapter 6 - Personalized medicine in oncology dealmaking directory by specific technology type

Chapter 7 - Partnering resource center

Companies Mentioned

- Abbott

- Amgen

- Astellas

- AstraZeneca

- Bayer

- Biogen Idec

- Boehringer Ingelheim

- Bristol-Myers Squibb

- Celgene

- Eisai

- Eli Lilly

- Gilead Sciences

- GlaxoSmithKline

- Johnson & Johnson

- Merck & Co

- Merck KGaA

- Novartis

- Pfizer

- Roche

- Sanofi

- Servier

- Teva

For more information visit http://www.researchandmarkets.com/research/mw7c2k/personalized

Research and Markets
Laura Wood, Senior Manager.
[e-mail]
U.S. Fax: [phone]
Fax (outside U.S.): [phone]
Sector: Healthcare and Medical Devices